Bank of America’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4K Buy
+10,337
New +$26.7K ﹤0.01% 5638
2026
Q1
Sell
-4
Closed -$10 5836
2025
Q4
$10 Buy
4
+1
+33% +$7 ﹤0.01% 7196
2025
Q3
$18 Buy
3
+2
+200% +$12 ﹤0.01% 8171
2025
Q2
$9 Hold
1
﹤0.01% 8300
2025
Q1
$15 Hold
1
﹤0.01% 8175
2024
Q4
$19 Buy
+1
New +$19 ﹤0.01% 8030
2024
Q3
Hold
0
8077
2023
Q1
Hold
0
-$4 7815
2022
Q4
Hold
0
8141

Other funds holding BJDX

Bank of America's BJDX Position: Q2 2026 in Review

Bank of America opened a new position in Bluejay Diagnostics (BJDX) in Q2 2026: 10,337 shares worth $12.4K. The stake represents ﹤0.01% of the portfolio and ranks #5638 among its holdings. This is a return to the name: Bank of America previously reported a position in BJDX as recently as Q4 2025.

Bank of America first reported a position in BJDX in Q4 2024 and has held it in 6 quarters since. 8 funds tracked by Wall St. Rank hold BJDX as of Q2 2026.

  • Bank of America held 10,337 shares of Bluejay Diagnostics worth $12.4K as of Q2 2026.
  • Bluejay Diagnostics was a new Bank of America position in Q2 2026.
  • Bluejay Diagnostics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5638 holding.
  • Bank of America first reported a position in Bluejay Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.